Sattva Sukun submits audited FY26 results to BSE
Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss in the prior quarter. Total income for the year decreased to ₹423.70 lakh, while expenses rose to ₹420.78 lakh.

*this image is generated using AI for illustrative purposes only.
Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE Limited. The results were published in Mumbai Lakshadweep (Marathi) and Active Times (English) in compliance with Regulation 47(l)(a) of the SEBI (LODR) Regulations, 2015. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss of ₹56.97 lakh in the quarter ended March 31, 2026.
The Board approved the financial results at a meeting held on June 4, 2026, which was rescheduled from May 30, 2026, to complete the audit process. M/s. SSRV & Associates, the statutory auditors, issued an unmodified opinion on the financial statements. Total income from operations for the year stood at ₹423.70 lakh, a decrease from ₹566.69 lakh in the previous year. For the quarter, total income was ₹33.41 lakh compared to ₹131.51 lakh in the corresponding period of the previous year.
Financial Performance
The company reported a profit before tax of ₹2.92 lakh for FY26, significantly lower than ₹318.78 lakh in FY25. Total expenses for the year increased to ₹420.78 lakh from ₹247.91 lakh in the previous year. The basic earnings per share (EPS) for FY26 was ₹0.00, compared to ₹0.13 in the previous year.
| Metric | Q4FY26 (₹ in Lacs) | Q4FY25 (₹ in Lacs) | FY26 (₹ in Lacs) | FY25 (₹ in Lacs) |
|---|---|---|---|---|
| Total Income | 33.41 | 131.51 | 423.70 | 566.69 |
| Total Expenses | 109.32 | 40.63 | 420.78 | 247.91 |
| Net Profit/Loss | (56.97) | 84.22 | 16.52 | 249.02 |
| Basic EPS | (0.01) | 0.04 | 0.00 | 0.13 |
Rights Issue Utilization
During the financial year 2025-26, the company allotted 19,16,01,248 equity shares on a rights issue basis, raising ₹19.16 crore. The funds were utilized for working capital, business expansion, and investment in subsidiaries. The company confirmed there was no deviation in the use of funds raised.
Trading Window Closure
The trading window for designated persons and their immediate relatives remains closed. The window closed on April 01, 2026, and will reopen 48 hours after the conclusion of the Board Meeting, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE280E01038/403ed9a6-2f51-487d-840a-2be9d23fcd23.pdf
Historical Stock Returns for Sattva Sukun Lifecare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.33% | +1.33% | 0.0% | +31.03% | -19.15% | -70.54% |
What specific strategies will the company implement to reverse the decline in total income from operations?
How will the ₹19.16 crore raised from the rights issue specifically drive business expansion and improve future profitability?
What measures are being taken to control the significant surge in total expenses observed during FY26?
































